/PRNewswire/ Edwards Lifesciences (NYSE: EW) today announced it received approval from the U.S. Food and Drug Administration (FDA) for the MITRIS RESILIA.
/PRNewswire/ Edwards Lifesciences Corporation (NYSE: EW) will discuss the company s strategy for longer-term growth, provide an update on its technology.
/PRNewswire/ Edwards Lifesciences Corporation (NYSE: EW) will discuss the company s strategy for longer-term growth, provide an update on its technology.